je.st
news
Tag: vivus
Vivus - Qsymia Sales Point To Inability To Grow In Space
2016-03-14 15:08:16| Biotech - Topix.net
Vivus investors seem to want to hold onto the faith that somehow the anti-obesity drug Qsymia will suddenly see a shift to the positive that can turn around the company. The reality is that Vivus has cut marketing expenses as far as it can, and that insurance companies are dropping coverage, leaving Vivus at an interesting crossroads.
Premarket Biotech Digest: My Response, Gilead In 2016, Blow For Vivus
2015-12-31 17:25:58| Biotech - Topix.net
Firstly here is the MBBS degree attached. I also have an MD and a PhD . I am traveling in Europe, but if necessary, I will upload those once I return.
Tags: response
blow
digest
biotech
Vivus: Qsymia Sales See Expected Thanksgiving Drop
2015-12-10 14:53:24| Biotech - Topix.net
Vivus investors saw sales of Qsymia dip this past week in large part due to the Thanksgiving holiday. Script numbers showed a 19% dip to about 8,600, but it was good enough for second place in the branded anti-obesity pill space.
Tags: sales
expected
drop
thanksgiving
Vivus: Is Icahn The Last Hope?
2015-10-01 12:05:21| Real Estate - Topix.net
Activist investor Carl Icahn earlier this month offered to acquire all of the outstanding 4.50% Convertible Senior Notes due 2020 of Vivus , the struggling biotechnology company. Icahn's unsolicited offer, although for convertible notes, sparked a rally in VVUS's shares.
Vivus - Qsymia Scripts Pass 11,000 For First Time In 2015
2015-03-14 17:21:11| Biotech - Topix.net
Vivus saw sales of the anti-obesity drug Qsymia move above 11,000 for the first time this year, according to industry tracker IMS Health. Last week, script sales were just under 11,400 and are now essentially challenging all time highs.